The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / September / Rare Disease AI Puts Variants in Focus
Clinical care Technology and innovation Digital Pathology Digital and computational pathology Genetics and epigenetics

Rare Disease AI Puts Variants in Focus

aiDIVA combines genomic evidence, phenotype matching, machine learning, and language models

09/24/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

4 Topic Commentaries

Rare Disease AI Puts Variants in Focus

Rare Disease AI Puts Variants in Focus

  • Debora Marks
    Debora Marks, PhD

    Computational genomics / systems biology

    •

    Harvard Medical School

    Our goal was to develop a model that ranks variants by disease severity — providing a prioritized, clinically meaningful view of a person’s genome.

    Source
  • Yi Xing
    Yi Xing, PhD

    Computational and genomic medicine / transcriptomics

    •

    Children’s Hospital of Philadelphia

    RNA is a powerful modality for the diagnosis of rare diseases.

    Source
  • Eric Klee
    Eric Klee, PhD

    Bioinformatics / genomic medicine

    •

    Mayo Clinic

    We're seeing dramatic growth in knowledge around what causes genetic disease, so we wanted to create a system to consistently track these discoveries.

    Source
  • Hyun-Hwan Jeong
    Hyun-Hwan Jeong, PhD

    Pediatric neurology / AI-assisted variant interpretation

    •

    Baylor College of Medicine

    Identifying whether a particular genetic change or variant is harmful or an innocent bystander is crucial for diagnosing these conditions, but the process requires sifting through large amounts of data, a complex and time-consuming task.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.